CR
Cancer Research Institute

CRI Technology Impact Award

Pays tenure-track researchers up to $600,000 to build unproven cancer immunotherapy technology.

OpenCancer Research InstituteUnited States

Applications run in two stages: a Letter of Intent, then an invited full proposal for candidates CRI selects by mid-February. Winning projects receive seed funding of up to $600,000 over two to four years, plus indirect costs of up to 10% of the award paid to the institution. Awards can only start on the first of a month, no earlier than July 1.

The award funds early-stage, not-yet-built technology concepts that could transform cancer immunotherapy: computational systems biology, advanced profiling technologies, real-time visualization of immune response, complex culture systems that model tumor-immune interaction, or new therapeutic technologies. It will not fund refinement of an existing technology or clinical trials themselves, though samples from an already-funded trial can support the work.

CycleiHow often this grant runs - e.g. annually, on a rolling basis, or a one-off call.No fixed schedule
Next deadlineiThe next date applications are due. Rolling means you can apply any time.16 Nov 2026
Decision timeiTypical time from the deadline to the funder's decision.-
Project durationiHow long the funded work is expected to run.24–48 months
Award typeiThe form of funding - grant, equity, loan, tax credit, etc.Grant
Match fundingiThe share of project costs you must cover yourself. 0% = fully funded.-
Funding pooliThe total budget available across all awards in this round.-

Sign up free to see the funding breakdown

Sign up free to see the industries in scope

Sign up free to see the full eligibility

Sign up free to see how to apply

Sign up free to see what you submit

Sign up free to see how they score you

Sign up free to see the timeline

Sign up free to see where teams trip up

Guides for this application

All guides →